Advertisement

Surgery Today

, Volume 50, Issue 1, pp 68–75 | Cite as

Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404)

  • Kazuya Nakagawa
  • Jun WatanabeEmail author
  • Mitsuyoshi Ota
  • Yusuke Suwa
  • Shinsuke Suzuki
  • Hirokazu Suwa
  • Masashi Momiyama
  • Atsushi Ishibe
  • Yusuke Saigusa
  • Takeharu Yamanaka
  • Chikara Kunisaki
  • Itaru Endo
Original Article
  • 152 Downloads

Abstract

Purpose

We conducted a prospective study to evaluate the efficacy and safety of postoperative enoxaparin for the prevention of venous thromboembolism (VTE) after laparoscopic surgery for colorectal cancer (LAC) in Japanese patients.

Methods

The subjects of this multicenter, open-label randomized-controlled trial were 121 patients who underwent LAC between September 2015 and May 2017. The patients were randomly allocated to receive intermittent pneumatic compression (IPC) with enoxaparin (20 mg, twice daily), started 24–36 h after surgery and continued until discharge (Enoxaparin group; n = 61), or IPC alone (IPC group; n = 60). The primary endpoint was the incidence of VTE on day 28 after surgery. The safety outcome was the incidence of any bleeding during treatment and follow-up.

Results

The incidence of VTE on day 28 after surgery was 12.3% (7/57 patients) in the enoxaparin group and 11.9% (7/59 patients) in the IPC group ((p = 1.00). One of the 57 patients (1.8%) in the enoxaparin group and none in the IPC group experienced a bleeding event.

Conclusions

It may be unnecessary to give enoxaparin to all Japanese patients for the prevention of VTE after LAC.

The UMIN Clinical Trials Registry number was UMIN000018633.

Keywords

Colorectal cancer Laparoscopic surgery Enoxaparin Venous thromboembolism Thromboprophylaxis 

Notes

Compliance with ethical standards

Conflict of interest

The authors have no conflicts of interest or financial ties to disclose.

References

  1. 1.
    Donati MB. Cancer and thrombosis. Haemostasis. 1994;24:128–31.PubMedGoogle Scholar
  2. 2.
    Ambrus JL, Ambrus CM, Mink IB, Pickren JW. Causes of death in cancer patients. J Med. 1975;6:61–4.PubMedGoogle Scholar
  3. 3.
    Gezelius C, Eriksson A. Neoplastic disease in a medicolegal autopsy material. A retrospective study in northern Sweden. Z Rechtsmed. 1988;101:115–30.PubMedGoogle Scholar
  4. 4.
    Svendsen E, Karwinski B. Prevalence of pulmonary embolism at necropsy in patients with cancer. J Clin pathol. 1989;42:805–9.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008;358:1037–52.PubMedGoogle Scholar
  6. 6.
    Sakon M, Maehara Y, Yoshikawa H, Akaza H. Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan. J Thromb Haemost. 2006;4:581–6.PubMedGoogle Scholar
  7. 7.
    Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S–75S.PubMedGoogle Scholar
  8. 8.
    Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913–30.PubMedGoogle Scholar
  9. 9.
    Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318:1162–73.PubMedGoogle Scholar
  10. 10.
    Wille-Jorgensen P, Rasmussen MS, Andersen BR, Borly L. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. Cochrane Database Syst Rev. 2003;4:001217.Google Scholar
  11. 11.
    Kerkez MD, Culafic DM, Mijac DD, Rankovic VI, Lekic NS, Stefanovic DZ. A study of pulmonary embolism after abdominal surgery in patients undergoing prophylaxis. World J Gastroenterol. 2009;15:344–8.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Moneta GL, Bedford G, Beach K, Strandness DE. Duplex ultrasound assessment of venous diameters, peak velocities, and flow patterns. J Vasc Surg. 1988;8:286–91.PubMedGoogle Scholar
  13. 13.
    Nguyen NT, Cronan M, Braley S, Rivers R, Wolfe BM. Duplex ultrasound assessment of femoral venous flow during laparoscopic open gastric bypass. Surg Endosc. 2003;17:285–90.PubMedGoogle Scholar
  14. 14.
    Nguyen NT, Hinojosa MW, Fayad C, Varela E, Konyalian V, Stamos MJ, et al. Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery. Ann Surg. 2007;246:1021–7.PubMedGoogle Scholar
  15. 15.
    Shapiro R, Vogel JD, Kiran RP. Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery: an additional benefit of the minimally invasive approach? Dis Colon Rectum. 2011;54:1496–502.PubMedGoogle Scholar
  16. 16.
    Cimminiello C, Prandoni P, Agnelli G, Di Minno G, Polo Friz H, Scaglione F, et al. Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a metaanalysis. Intern Emerg Med. 2017;12:1291–305.PubMedGoogle Scholar
  17. 17.
    Nagata C, Tanabe H, Takakura S, Narui C, Saito M, Yanaihara N, et al. Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy. J Obstet Gynaecol Res. 2015;41:1440–8.PubMedGoogle Scholar
  18. 18.
    Hashimoto D, Nakagawa S, Umezaki N, Yamao T, Kitano Y, Yamamura K, et al. Efficacy and safety of postoperative anticoagulation prophylaxis with enoxaparin in patients undergoing pancreatic surgery: a prospective trial and literature review. Pancreatology. 2017;17:464–70.PubMedGoogle Scholar
  19. 19.
    Dranitsaris G, Jelincic V, Choe Y. Meta-regression analysis to indirectly compare prophylaxis with dalteparin or enoxaparin in patients at high risk for venous thromboembolic events. Clin Appl Thromb Hemost. 2012;18:233–42.PubMedGoogle Scholar
  20. 20.
    Sakon M, Kobayashi T, Shimazui T. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study. Thromb Res. 2010;125:e65–70.PubMedGoogle Scholar
  21. 21.
    Yoshida N, Baba Y, Miyamoto Y, Iwatsuki M, Hiyoshi Y, Ishimoto T, et al. Prophylaxis of postoperative venous thromboembolism using enoxaparin after esophagectomy: a prospective observational study of effectiveness and safety. Ann Surg Oncol. 2018;25:2434–40.PubMedGoogle Scholar
  22. 22.
    Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr., Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251:344–50.PubMedGoogle Scholar
  23. 23.
    Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest. 2012;141:e227S.PubMedPubMedCentralGoogle Scholar
  24. 24.
    JCS Joint Working Group. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). Circ J. 2011;75:1258–81.Google Scholar
  25. 25.
    Zaghiyan KN, Sax HC, Miraflor E, Cossman D, Wagner W, Mirocha J, Gewertz B, Fleshner P, Cedars-Sinai DVT Study Group. Timing of chemical thromboprophylaxis and deep vein thrombosis in major colorectal surgery: a randomized clinical trial. Ann Surg. 2016;264:632–9.PubMedGoogle Scholar
  26. 26.
    ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg. 1997;84:1099–103.Google Scholar
  27. 27.
    McLeod RS, Geerts WH, Sniderman KW, Greenwood C, Gregoire RC, Taylor BM, et al. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg. 2001;233:438–44.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Simonneau G, Laporte S, Mismetti P, Derlon A, Samii K, Samama CM, et al. A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0 3 mL) vs enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer. J Thromb Haemost. 2006;4:1693–700.PubMedGoogle Scholar
  29. 29.
    White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost. 2005;93:298–305.PubMedGoogle Scholar
  30. 30.
    Zakai NA, McClure LA. Racial differences in venous thromboembolism. J Thromb Haemost. 2011;9:1877–82.PubMedGoogle Scholar
  31. 31.
    Surgical Care Improvement Project–Quality Improvement Measure VTE2. https://www.qualitynet.org/dcs/ContentServer?cid=1176726358615&pagename=QnetPublic%2FPage%2FQnetTier3&c=Page. Accessed on 11 Jan 2019.
  32. 32.
    Rasmussen MS, Jørgensen LN, Wille-Jørgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009;21:CD004318.Google Scholar
  33. 33.
    Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg. 2014;259:665–9.PubMedGoogle Scholar
  34. 34.
    Verheijen PM, Stevenson AR, Stitz RW, Clark DA, Clark AJ, Lumley JW. Prolonged use of thromboprophylaxis may not be necessary in laparoscopic colorectal surgery. Int J Colorectal Dis. 2011;26:755–9.PubMedGoogle Scholar
  35. 35.
    Cheung HY, Chung CC, Yau KK, Siu WT, Wong SK, Chiu E, et al. Risk of deep vein thrombosis following laparoscopic rectosigmoid cancer resection in Chinese patients. Asian J Surg. 2008;31:63–8.PubMedGoogle Scholar
  36. 36.
    Richardson WS, Apelgren K, Fanelli RD, Earle D. Deep venous thrombosis prophylaxis in laparoscopy: an evidence-based review. Surg Endosc. 2007;21:2335–8.PubMedGoogle Scholar
  37. 37.
    Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107:I9–I16.PubMedGoogle Scholar
  38. 38.
    Baumgartner JM, McKenzie S, Block S, Costantini TW, Lowy AM. Prophylactic enoxaparin doses may be inadequate in patients undergoing abdominal cancer surgery. J Surg Res. 2018;221:183–9.PubMedGoogle Scholar
  39. 39.
    Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J Orthop Sci. 2008;13:442–51.PubMedGoogle Scholar
  40. 40.
    White RH, McGahan JP, Daschbach MM, Hartling RP. Diagnosis of deep-vein thrombosis using duplex ultrasound. Ann Intern Med. 1989;111:297–304.PubMedGoogle Scholar
  41. 41.
    Becker DM, Philbrick JT, Abbitt PL. Real-time ultrasonography for the diagnosis of lower extremity deep venous thrombosis. The wave of the future? Arch Intern Med. 1989;149:1731–4.PubMedGoogle Scholar
  42. 42.
    Cogo A, Lensing AW, Wells P, Prandoni P, Buller HR. Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosis. Haemostasis. 1995;25:27–39.PubMedGoogle Scholar
  43. 43.
    Guyatt GH, Eikelboom JW, Gould MK, Garcia DA, Crowther M, Murad MH, et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e185S–e194S.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Kazuya Nakagawa
    • 1
  • Jun Watanabe
    • 2
    Email author
  • Mitsuyoshi Ota
    • 1
  • Yusuke Suwa
    • 1
  • Shinsuke Suzuki
    • 1
  • Hirokazu Suwa
    • 3
  • Masashi Momiyama
    • 1
  • Atsushi Ishibe
    • 1
  • Yusuke Saigusa
    • 4
  • Takeharu Yamanaka
    • 4
  • Chikara Kunisaki
    • 2
  • Itaru Endo
    • 1
  1. 1.Department of Gastroenterological SurgeryYokohama City University Graduate School of MedicineYokohamaJapan
  2. 2.Department of Surgery, Gastroenterological CenterYokohama City University Medical CenterYokohamaYokohamaJapan
  3. 3.Department of SurgeryYokosuka Kyosai HospitalYokosukaJapan
  4. 4.Department of BiostatisticsYokohama City University Graduate School of MedicineYokohamaJapan

Personalised recommendations